Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Pak J Pharm Sci ; 36(2(Special)): 595-599, 2023 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-37548195

RESUMO

To compare the effectiveness and safety of spironolactone versus lecithin-bound iodine in patients with central serous retinopathy (CSR). Chinese diabetes patients aged>18 years with CSR with persistent increased level of subretinal fluid (SRF) were enrolled. Subjects were randomized to receive either oral lecithin-bound iodine (390µg/kg/day) or oral spironolactone (50mg/day) for 6 months. A total of 200 patients were randomized and completed the study. Compared to spironolactone group, patients treated with lecithin-bound iodine had greater proportion of eye with complete resolution (87% vs 81%, p>0.005). Higher improvement in height of SRF was observed in lecithin-bound iodine-treated patients as compared with Spironolactone-treated patients (91.2[87.5] vs 142.5 [121.1]; p>0.005). However, no statistically significant difference was observed on none of comparisons. Compared to Spironolactone, the patients treated with lecithin-bound iodine had greater improvement in lesion size, central macular thickness and best-corrected visual acuity. However, no statistically significant difference was observed in any of parameter assessed. (p>0.005). The results of the present study suggested that the lecithin-bound iodine was found more effective (nnumerically) than spironolactone in Chinese diabetes patients with CSR.


Assuntos
Coriorretinopatia Serosa Central , Diabetes Mellitus , Lecitinas , Espironolactona , Humanos , Coriorretinopatia Serosa Central/diagnóstico , Coriorretinopatia Serosa Central/tratamento farmacológico , Coriorretinopatia Serosa Central/patologia , População do Leste Asiático , Lecitinas/efeitos adversos , Lecitinas/uso terapêutico , Antagonistas de Receptores de Mineralocorticoides , Estudos Prospectivos , Espironolactona/efeitos adversos , Espironolactona/uso terapêutico , Tomografia de Coerência Óptica/métodos , Resultado do Tratamento , Acuidade Visual , Óleo Iodado , Halogenação
2.
Vestn Oftalmol ; 129(5): 73-81, 2013.
Artigo em Russo | MEDLINE | ID: mdl-24261283

RESUMO

A variety of subthreshold laser methods that enable selective and precise treatment of chorioretinal microstructures, thus decreasing the risk of negative changes in retina and choriocapillaries, is used in current ophthalmological practice. This comparative pathomorphological and histochemical study allowed characterizing structural changes and functional activity of chorioretinal cells after application of different subthreshold laser technologies.


Assuntos
Coriorretinopatia Serosa Central/radioterapia , Histocitoquímica/métodos , Terapia com Luz de Baixa Intensidade/métodos , Epitélio Pigmentado da Retina/patologia , Animais , Proliferação de Células , Coriorretinopatia Serosa Central/patologia , Modelos Animais de Doenças , Feminino , Seguimentos , Masculino , Coelhos , Epitélio Pigmentado da Retina/efeitos da radiação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA